Sweden's import of insulin in dosage forms has shown a consistent annual growth trend from 2024 to 2028 with slight year-on-year increases. The value in 2023 stood at 326.50 Thousand Kilograms. The import values indicated for the forecast years are as follows: 328.53 in 2024, 330.73 in 2025, 332.88 in 2026, 334.99 in 2027, and 337.06 in 2028.
Year-on-Year Variation (YoY) in percentages:
- 2024: Growth from 2023 by 0.62%
- 2025: Growth from 2024 by 0.67%
- 2026: Growth from 2025 by 0.65%
- 2027: Growth from 2026 by 0.63%
- 2028: Growth from 2027 by 0.62%
The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is approximately 0.64%, indicating a steady increase in the import volume of insulin in dosage forms.
Future trends to watch for:
- Technological advancements in insulin formulation and delivery.
- Changes in health policies and diabetes management guidelines in Sweden.
- Growth trends in the incidences of diabetes and related health conditions.
- Potential trade regulations and market accessibility influencing import volumes.
